Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

CNS Summit 2015 Drives Collaborative Efforts to Shape the Future of Drug Development
By: PR Newswire Association LLC. - 12 Oct 2015Back to overview list

BOCA RATON, Fla., Oct. 12, 2015 /PRNewswire/ -- CNS Summit opened with a keynote panel focused on examining the future impact of Silicon Valley on drug development. This panel complemented the Clinical Trials of the Future initiative which brings together experts in clinical trials, technology and other relevant disciplines to shape the future of how clinical trials are conducted. The goal is to leverage upcoming trends to enable more efficient and successful drug development resulting in the acceleration of new treatments reaching patients.

Currently, the CTF initiative has five Domains: 
    (1) Connected Clinical Trials 
    (2) Ethics of Innovation
    (3) Clinical Development of the Future 
    (4) Clinical Trial Site of the Future 
    (5) Clinical Assessments of the Future

CNS Summit Scientific Program Committee Co-Chair Judith Dunn of Roche commented: "CNS Summit has, from the beginning, been a forward-looking meeting, focused on leveraging innovation and collaboration to advance the science of drug development, bringing new treatment to patients. The Clinical Trials of the Future initiative is the latest example of this."

About the CNS Summit
The CNS Summit 2015 took place October 8th through the 11th. Participants included leaders from pharmaceutical, biotechnology, and service companies, as well as research investigators. Founded by drug developers, the core principles of Collaboration, Innovation, and Technology drive the CNS Summit's programs and initiatives to shape the future of drug development. The CNS Summit is differentiated by its programming and is known for its innovative content and format, as well as the strong emphasis on networking and collaborating between different stakeholders to solve pressing challenges in drug development. CNS Summit is the most impactful gathering of drug development leaders from pharmaceutical and biotech companies, research sites, and service companies.

CNS Summit 2016 will be held in Boca Raton, Florida, from October 27th—30th, 2016.

For inquiries please contact:

Erica Moore
Email
858-324-1823
www.cnssummit.org

SOURCE CNS Summit

Copyright 2015 PR Newswire Association LLC. Back to overview list
to the top ↑